Quarterly report pursuant to Section 13 or 15(d)

Related Party Agreements (Details)

v3.20.2
Related Party Agreements (Details)
 1 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2016
USD ($)
Mar. 17, 2015
USD ($)
item
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Management Services Agreement [Member]            
Related Party Transaction [Line Items]            
Number of period   5 years        
Annual Consulting Fee   $ 500,000        
Increase In Annual Consulting Fee   1,000,000.0        
Excess In Net Assets Value   100,000,000        
Costs and Expenses, Related Party     $ 125,000 $ 125,000 $ 375,000 $ 375,000
Fortress Biotech, Inc [Member] | Founders Agreement [Member]            
Related Party Transaction [Line Items]            
Long-term Debt, Gross   $ 2,800,000        
Issuance of Common Stock, Percentage of Outstanding Diluted Equity   2.50%        
Number of Business Days   5 days        
Voting equity, Percentage of Equity or Debt Financing   2.50%        
Cash Fee, Percentage of Annual Net Sales   4.50%        
Cash Fees, Maximum Number of Days   90 days        
Control Fees, Number of Times | item   5        
Control Fees, Monthly Net Sales   12 months        
Cash Fee, Percentage of Monthly Net Sales   4.50%        
Agreement Term   15 years        
Caribe Bioadvisors LLC [Member]            
Related Party Transaction [Line Items]            
Costs and Expenses, Related Party     28,000 28,000 84,000 76,000
Annual Advisory Service Fee $ 60,000          
Caribe Bioadvisors LLC [Member] | Equity Incentive Grants [Member]            
Related Party Transaction [Line Items]            
Costs and Expenses, Related Party     $ 13,000 $ 13,000 $ 39,000 $ 31,000